POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
High Impact

North Carolina Bill Allows Pharmacists to Test and Treat Certain Illnesses and Mandates Equal Insurance Coverage

Original title: Pharmacists/Test and Treat.

Last action · April 3, 2025: Ref to the Com on Health, if favorable, Appropriations, if favorable, Rules, Calendar, and Operations of the House (House action)Sponsors: Cody Huneycutt and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Would Do

Pharmacists in North Carolina are newly authorized to order and perform s and treat conditions such as influenza, COVID-19, and strep throat using approved medications under statewide protocols, effective October 1, 2025. Additionally, health benefit plans and insurers are required to provide fair and equitable coverage for healthcare services performed by pharmacists within their scope of practice if those services would be covered when performed by other healthcare providers.

Why it matters

Expands direct healthcare access for patients by allowing local pharmacies to diagnose and treat common illnesses without a prior doctor's visit, while requiring health insurance plans to reimburse pharmacists on the same terms as other medical professionals.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Pharmacists

Pharmacists are granted new authority to order and perform CLIA-waived tests and treat specific illnesses, and are guaranteed fair reimbursement for equivalent healthcare services.

Directly affected

Insurers and Health Benefit Plans

Insurers must cover healthcare services provided by pharmacists under the same conditions as other healthcare providers and accept delegated credentialing agreements.

Directly affected

Patients

Patients gain direct access to testing and treatment for common illnesses like COVID-19 and influenza at local pharmacies with insurance coverage.

Key Facts

  • Pharmacists are authorized to order and perform CLIA-waived tests to assist with clinical decision-making and treat influenza, COVID-19, pharyngitis caused by group A streptococcus, and other screened health conditions.
  • Pharmacists are explicitly prohibited from treating any health condition under the new testing provisions using controlled substances classified in Schedules I through IV.
  • Health benefit plans offered by insurers in North Carolina must cover healthcare services provided by a pharmacist if performed within their licensed lawful scope of practice and covered if performed by another provider.
  • Insurers that delegate credentialing agreements for pharmacists to a contracted healthcare facility must accept that credentialing for all pharmacists employed by or contracted with those facilities.
Show all 7 facts
  • Third-party administrators and pharmacy benefits managers are made subject to all statutory requirements relating to the coverage of prescription drugs and pharmacy services that apply to insurers.
  • The State Health Director, in consultation with the North Carolina Board of Pharmacy and the North Carolina Medical Board, must develop statewide protocols including patient parameters necessitating referral to primary, urgent, or emergency care.
  • The provisions regarding pharmacist testing, treatment, and insurance coverage become effective on October 1, 2025.

Frequently Asked Questions

What specific illnesses can pharmacists test and treat under this bill?
Pharmacists can order and perform s to treat influenza, COVID-19, pharyngitis caused by group A streptococcus, and other health conditions screened by utilizing a CLIA-waived test.
Will insurance plans be required to pay for services rendered by a pharmacist?
Yes, health benefit plans offered by insurers in the State must cover healthcare services provided by a pharmacist if the service was within their scope of practice and would have been covered if performed by another healthcare provider.
Can pharmacists prescribe controlled substances under these new testing and treatment rules?
No, a pharmacist is strictly prohibited from treating any health condition under this section with any controlled substance classified in Schedules I through IV.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

3 actions
  1. Apr 3, 2025House
    Ref to the Com on Health, if favorable, Appropriations, if favorable, Rules, Calendar, and Operations of the House
  2. Apr 3, 2025House
    Passed 1st Reading
  3. Apr 2, 2025HouseIntroduced
    Filed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

North Carolina Board of Pharmacy, Food and Drug Administration, State Health Director and 1 more
OrganizationNorth Carolina Board of Pharmacy“Establishes guidelines and approves medications for pharmacist treatment protoco”Map →
OrganizationFood and Drug Administration“Authorizes laboratory tests waived under CLIA”Map →
PersonState Health Director“Tasked with developing statewide protocols in consultation with pharmacy and med”Map →
OrganizationNorth Carolina Medical Board“Consulted for establishing joint subcommittee guidelines and statewide protocols”Map →

Sources

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy30
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record